中药过程控制技术国家中医药管理局重点研究室简介

Published: 2017-12-24 16:00

The "Key Laboratory of Traditional Chinese Medicine Process Control Technology" is a construction project of the first batch of key laboratories approved by the State Administration of Traditional Chinese Medicine in 2009. Undertaken by the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, it was jointly established by the Research Center for Quality Standards of Chinese Medicine, the Research Center for Chinese Medicinal Preparations, and the Research Center for Processing of Chinese Medicine. Dr. Wang Zhimin serves as the director of the Key Laboratory. After three years of development, the laboratory successfully passed the acceptance inspection by the State Administration of Traditional Chinese Medicine in 2012, becoming one of the first to do so.

      重点研究室的研究方向:1、中药药效物质基础及其质量标准研究;2、中药炮制工艺、过程控制和质量标准研究;3、中药制剂生产和质量标准研究。

During the construction period from 2009 to 2012, the Key Research Laboratory undertook 18 national-level projects with a total funding of 3792 million CNY; developed 1 new methods, 12 novel traditional Chinese medicine (TCM) production processes, and 3 new pieces of equipment; published 270 scientific papers, including 28 indexed in SCI with a maximum impact factor of 10.178; authored 1 monographs; filed 18 invention patent applications and obtained authorization for 3 patents; formulated and completed 50 national standards and received {14] provincial/ministry-level science and technology awards.

      2013-2016年的后建设期中,重点研究室共承担国家级课题84项,总经费 20590万元,横向服务达3000余万元;发表科技论文 402篇,其中SCI 132 篇,出版专著17部,其中英文专著2部;申请国家发明专利14项,获得国家发明专利授权15项,完成国家标准8项,获得省部级科技奖励8项。

      2017年,国家中医药管理局对建设期满3年的128个重点研究室进行了阶段性评估。通过阶段评估单位120个,其中优秀9个,合格111个。“中药过程控制技术重点研究室”获得优秀,排名第3。